text: Protection of reproduction function in women with Hodgkin's disease in the course of polychemotherapy | Meta
  Protection of reproduction function in women with Hodgkin's disease in the course of polychemotherapy
  E V IgnashinaD E Shilin
  To evaluate efficiency of estrogen-gestagen treatment for protection of the ovaries during polychemotherapy. Ultrasonography of the pelvic organs, radioimmunoassay of LH, FSH, prolactin, E2, testosterone were performed in 95 women of child-bearing age with different stages of Hodgkin's disease. Cytostatic therapy of Hodgkin's disease had ovariotoxic effects and led to amenorrhea in 83% of the examinees. Regular estrogen-gestagen treatment protected ovaries in 86% of the patients. It is recommended for women to take estrogen-gestagen drugs to protect ovaries during polychemotherapy of Hodgkin's disease.
  PMID: 10612170
  Combined chemotherapy for hemoblastoses and therapy for acute respiratory failure in intensive care conditions
  G M GalstianA I Vorob'ev
  Ia K MangasarovaA I Vorob'ev
  The use of autologous peripheral blood stem cells as a hemopoietic support during polychemotherapy of children with soft tissue sarcomas
  N M IvanovaR S Ravshanova
  A K MorozovaA I Vorob'ev
  Coagulation system in patients with blood malignancies treated with estrogens in the course of cytostatic therapy